(Circulation. 2001;103:1128.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Research Center, Montreal Heart Institute (J.-G.B., J.-F. Tanguay, J-F. Théorêt, Y.M.), the University of Montreal (J.-G.B., J.-F. Tanguay, J-F. Théorêt, Y.M.), Montreal, Quebec, Canada; and Wyeth/Genetics Institute (A.K., R.G.S.), Andover, Mass.
Correspondence to Yahye Merhi, Laboratory of Experimental Pathology, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec, Canada, H1T 1C8. E-mail merhi{at}icm.umontreal.ca
BackgroundP-selectin mediates leukocyte recruitment to activated platelets and endothelium through its high-affinity receptor P-selectin glycoprotein ligand-1 (PSGL-1). Platelet and leukocyte activation and binding have been reported after coronary angioplasty and were correlated with restenosis. We investigated the effect of a recombinant soluble PSGL-1 (rPSGL-Ig) on the adhesion of platelets and neutrophils and the development of restenosis after double arterial injury.
Methods and ResultsFour weeks after angioplasty of both carotid arteries in pigs, a second angioplasty was performed at the same sites, 15 minutes after a single administration of vehicle or rPSGL-1 (1 mg/kg IV). Animals were euthanized 1 hour, 4 hours, 1 week, or 4 weeks later. Adhesion of autologous 51Cr-platelets and 111In-neutrophils was quantified and histological/morphometric analyses were performed. Although rPSGL-Ig did not affect adherence of these cells 1 hour after injury, it significantly reduced the adhesion of platelets (50% at 4 hours and 85% at 1 week) and neutrophils (50% at 4 hours and 78% at 1 week) to deeply injured arteries. At 4 weeks, the residual lumen was 63% larger in rPSGL-Igtreated arteries as compared with control arteries (6.1±0.6 versus 3.8±0.1 mm2; P<0.002). The neointimal area was slightly reduced (0.5 in rPSGL-Ig versus 0.7 mm2 in control). The ratio of the external elastic lamina of injured to uninjured reference segments was >1 in treated arteries and <1 in control arteries.
ConclusionsP-selectin antagonism with rPSGL-Ig inhibits early platelet/leukocyte adhesion on injured arteries and reduces restenosis through a positive impact on vascular remodeling. Hence, rPSGL-Ig may have potential in the prevention of restenosis.
Key Words: restenosis remodeling glycoproteins platelets leukocytes
This article has been cited by other articles:
![]() |
H. Wang, W. Zhang, R. Tang, R. P. Hebbel, M. A. Kowalska, C. Zhang, J. D. Marth, M. Fukuda, C. Zhu, and Y. Huo Core2 1-6-N-Glucosaminyltransferase-I Deficiency Protects Injured Arteries From Neointima Formation in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. van Gils, J. J. Zwaginga, and P. L. Hordijk Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases J. Leukoc. Biol., February 1, 2009; 85(2): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bournazos, J. Rennie, S. P. Hart, K. A.A. Fox, and I. Dransfield Monocyte Functional Responsiveness After PSGL-1-Mediated Platelet Adhesion Is Dependent on Platelet Activation Status Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1491 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Bedard, V. Clerin, N. Sushkova, B. Tchernychev, T. Antrilli, C. Resmini, J. C. Keith Jr., J. K. Hennan, N. Kaila, S. DeBernardo, et al. Characterization of the Novel P-Selectin Inhibitor PSI-697 [2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] Quinoline-4-carboxylic acid] in Vitro and in Rodent Models of Vascular Inflammation and Thrombosis J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 497 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Geraldes, S. Gagnon, S. Hadjadj, Y. Merhi, M. G. Sirois, I. Cloutier, and J.-F. Tanguay Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ER{alpha}-mediated pathway Cardiovasc Res, August 1, 2006; 71(3): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wang, X. Zhou, Z. Zhou, N. Mal, L. Fan, M. Zhang, A. M. Lincoff, E. F. Plow, E. J. Topol, and M. S. Penn Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1584 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Costa and D. I. Simon Molecular Basis of Restenosis and Drug-Eluting Stents Circulation, May 3, 2005; 111(17): 2257 - 2273. [Full Text] [PDF] |
||||
![]() |
M. Martinez, M. Joffraud, S. Giraud, B. Baisse, M. P. Bernimoulin, M. Schapira, and O. Spertini Regulation of PSGL-1 Interactions with L-selectin, P-selectin, and E-selectin: ROLE OF HUMAN FUCOSYLTRANSFERASE-IV AND -VII J. Biol. Chem., February 18, 2005; 280(7): 5378 - 5390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanaba, K. Komura, M. Horikawa, Y. Matsushita, K. Takehara, and S. Sato P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition J. Leukoc. Biol., August 1, 2004; 76(2): 374 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Manka, S. B. Forlow, J. M. Sanders, D. Hurwitz, D. K. Bennett, S. A. Green, K. Ley, and I. J. Sarembock Critical Role of Platelet P-Selectin in the Response to Arterial Injury in Apolipoprotein-E-Deficient Mice Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Yanaba, K Takehara, and S Sato Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis Ann Rheum Dis, May 1, 2004; 63(5): 583 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Phillips, K. G. Barringhaus, J. M. Sanders, S. E. Hesselbacher, A. C. Czarnik, D. Manka, D. Vestweber, K. Ley, and I. J. Sarembock Single Injection of P-Selectin or P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Blocks Neointima Formation After Arterial Injury in Apolipoprotein E-Deficient Mice Circulation, May 6, 2003; 107(17): 2244 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Burger and D. D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood, April 1, 2003; 101(7): 2661 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. M. Molenaar, C. C. M. Appeldoorn, S. A. M. de Haas, I. N. Michon, A. Bonnefoy, M. F. Hoylaerts, H. Pannekoek, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists Blood, November 15, 2002; 100(10): 3570 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, M. S. Penn, F. Forudi, X. Zhou, K. Tarakji, E. J. Topol, A. M. Lincoff, and K. Wang Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1598 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Shebuski and K. S. Kilgore Role of Inflammatory Mediators in Thrombogenesis J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Barbaux, S. Blankenberg, H. J. Rupprecht, C. Francomme, C. Bickel, G. Hafner, V. Nicaud, J. Meyer, F. Cambien, and L. Tiret Association Between P-Selectin Gene Polymorphisms and Soluble P-Selectin Levels and Their Relation to Coronary Artery Disease Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1668 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Theoret, J.-G. Bienvenu, A. Kumar, and Y. Merhi P-Selectin Antagonism with Recombinant P-Selectin Glycoprotein Ligand-1 (rPSGL-Ig) Inhibits Circulating Activated Platelet Binding to Neutrophils Induced by Damaged Arterial Surfaces J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 658 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sarma, C. A. Laan, S. Alam, A. Jha, K. A.A. Fox, and I. Dransfield Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes Circulation, May 7, 2002; 105(18): 2166 - 2171. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |